The Royal Pharmaceutical Society (RPS) has secured a contract with the National Institute for Health Research (NIHR) to deliver a suite of e-learning modules to help pharmacy professionals "become more research active".
The new online resources - due to be launched next summer - are aimed at pharmacists and pharmacy technicians who may not have followed an academic career path or have had little or no experience of research delivery. The e-learning package will allow them to gain new skills so they feel more confident to engage with research and research opportunities.
Nine modules are being developed covering how to transform ideas into a research project, find and evaluate evidence and choose the appropriate research methods
whilst learning how to apply for research funding and deal with governance issues and publication.
Most people in Great Britain believe that new junior doctors, nurses and health care assistants are underpaid, senior doctors and matrons are paid about right,
and NHS CEOs are paid too much, according to a new study.
About half the people surveyed indicated that newly qualified junior doctors are paid too little, with this sentiment increasing to three in five (60 per cent) among
Labour voters.
The research conducted by the Policy Institute at King's College London, King's Business School, and Ipsos also showed that more people believe NHS staff overall were
badly paid than well paid.
Dr Nick Krachler, senior lecturer in Human Resource Management at King's Business School, said: "Our survey shows considerable alignment between public perception
of NHS pay levels and the claims of trade unions and professional associations that pay levels - which are determined by government after consultation from a Pay
Review Body - are unsatisfactory for frontline NHS roles."
He highlighted the urgent need to address healthcare workers' economic wellbeing, hoping that the new government will consider it in its upcoming negotiations with
junior doctors this week.
Following the publication of a new study by the British Medical Journal (BMJ) that estimates the economic impact and prevelance of hazardous NSAID
prescribing in England, the Royal Pharmaceutical Society (RPS) has underscored the pressing need for enhanced safety measures in medication management.
The study, led by RPS Fellow Rachel Elliott, reveals significant health and financial costs associated with the high-risk prescribing of oral non-steroidal
anti-inflammatory drugs (NSAIDs) among vulnerable populations.
James Davies, Director for England at the RPS, emphasised the critical findings of the research.
"Improving the safety of NSAID prescribing requires a multi-pronged approach, that educates and supports prescribers on the risk, as well as uses the skills
of pharmacists in the primary care team to help identify higher risk patients and prescribing scenarios," Davies remarked.
The study highlights that NSAIDs, while effective in managing pain and inflammation, are associated with serious adverse events, including gastrointestinal
bleeding, renal dysfunction, and cardiovascular issues.
